These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 34384464)

  • 1. Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery.
    Bai B; Vanderwall D; Li Y; Wang X; Poudel S; Wang H; Dey KK; Chen PC; Yang K; Peng J
    Mol Neurodegener; 2021 Aug; 16(1):55. PubMed ID: 34384464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer's disease.
    Wang H; Dey KK; Chen PC; Li Y; Niu M; Cho JH; Wang X; Bai B; Jiao Y; Chepyala SR; Haroutunian V; Zhang B; Beach TG; Peng J
    Mol Neurodegener; 2020 Jul; 15(1):43. PubMed ID: 32711556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting Alzheimer's Disease Molecular Substrates by Proteomics and Discovery of Novel Post-translational Modifications.
    Deolankar SC; Patil AH; Koyangana SG; Subbannayya Y; Prasad TSK; Modi PK
    OMICS; 2019 Jul; 23(7):350-361. PubMed ID: 31225774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease.
    Johnson ECB; Dammer EB; Duong DM; Yin L; Thambisetty M; Troncoso JC; Lah JJ; Levey AI; Seyfried NT
    Mol Neurodegener; 2018 Oct; 13(1):52. PubMed ID: 30286791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting Detergent-Insoluble Proteome in Alzheimer's Disease by TMTc-Corrected Quantitative Mass Spectrometry.
    Zaman M; Fu Y; Chen PC; Sun H; Yang S; Wu Z; Wang Z; Poudel S; Serrano GE; Beach TG; Li L; Wang X; Peng J
    Mol Cell Proteomics; 2023 Aug; 22(8):100608. PubMed ID: 37356496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-enriched plasma proteome is significantly altered in Alzheimer's disease.
    Guo Q; Ping L; Dammer EB; Duong DM; Yin L; Xu K; Shantaraman A; Fox EJ; Golde TE; Johnson ECB; Roberts BR; Lah JJ; Levey AI; Seyfried NT
    Mol Neurodegener; 2024 Oct; 19(1):67. PubMed ID: 39380021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.
    Hales CM; Dammer EB; Deng Q; Duong DM; Gearing M; Troncoso JC; Thambisetty M; Lah JJ; Shulman JM; Levey AI; Seyfried NT
    Proteomics; 2016 Dec; 16(23):3042-3053. PubMed ID: 27718298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer's disease: A literature review.
    Wesenhagen KEJ; Teunissen CE; Visser PJ; Tijms BM
    Crit Rev Clin Lab Sci; 2020 Mar; 57(2):86-98. PubMed ID: 31694431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep proteome profiling of the hippocampus in the 5XFAD mouse model reveals biological process alterations and a novel biomarker of Alzheimer's disease.
    Kim DK; Han D; Park J; Choi H; Park JC; Cha MY; Woo J; Byun MS; Lee DY; Kim Y; Mook-Jung I
    Exp Mol Med; 2019 Nov; 51(11):1-17. PubMed ID: 31727875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Aβ Antibody Aducanumab Regulates the Proteome of Senile Plaques and Closely Surrounding Tissue in a Transgenic Mouse Model of Alzheimer's Disease.
    Bastrup J; Hansen KH; Poulsen TBG; Kastaniegaard K; Asuni AA; Christensen S; Belling D; Helboe L; Stensballe A; Volbracht C
    J Alzheimers Dis; 2021; 79(1):249-265. PubMed ID: 33252074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer's disease.
    Rayaprolu S; Gao T; Xiao H; Ramesha S; Weinstock LD; Shah J; Duong DM; Dammer EB; Webster JA; Lah JJ; Wood LB; Betarbet R; Levey AI; Seyfried NT; Rangaraju S
    Mol Neurodegener; 2020 May; 15(1):28. PubMed ID: 32381088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer's disease.
    Modeste ES; Ping L; Watson CM; Duong DM; Dammer EB; Johnson ECB; Roberts BR; Lah JJ; Levey AI; Seyfried NT
    Mol Neurodegener; 2023 Jul; 18(1):48. PubMed ID: 37468915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.
    Robinson RA; Amin B; Guest PC
    Adv Exp Med Biol; 2017; 974():21-48. PubMed ID: 28353223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer's Disease Progression.
    Bai B; Wang X; Li Y; Chen PC; Yu K; Dey KK; Yarbro JM; Han X; Lutz BM; Rao S; Jiao Y; Sifford JM; Han J; Wang M; Tan H; Shaw TI; Cho JH; Zhou S; Wang H; Niu M; Mancieri A; Messler KA; Sun X; Wu Z; Pagala V; High AA; Bi W; Zhang H; Chi H; Haroutunian V; Zhang B; Beach TG; Yu G; Peng J
    Neuron; 2020 Mar; 105(6):975-991.e7. PubMed ID: 31926610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JUMPptm: Integrated software for sensitive identification of post-translational modifications and its application in Alzheimer's disease study.
    Poudel S; Vanderwall D; Yuan ZF; Wu Z; Peng J; Li Y
    Proteomics; 2023 Feb; 23(3-4):e2100369. PubMed ID: 36094355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of DISC1 on Alzheimer's disease cell models assessed by iTRAQ proteomics analysis.
    Lu J; Huang R; Peng Y; Wang H; Feng Z; Fan Y; Zeng Z; Wang Y; Wei J; Wang Z
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34981809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer disease pathology and the cerebrospinal fluid proteome.
    Dayon L; Núñez Galindo A; Wojcik J; Cominetti O; Corthésy J; Oikonomidi A; Henry H; Kussmann M; Migliavacca E; Severin I; Bowman GL; Popp J
    Alzheimers Res Ther; 2018 Jul; 10(1):66. PubMed ID: 30021611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyzing the glial proteome in Alzheimer's disease.
    Kim JH; Afridi R; Lee WH; Suk K
    Expert Rev Proteomics; 2023; 20(10):197-209. PubMed ID: 37724426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.